Improving Neuropsychological Rehabilitation for COVID-19 Patients
Zeitschrift für Neuropsychologie · 2023-06 · 34 (2) · 57-70
DOI: 10.1024/1016-264x/a000373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Neuropsychologie, 2023-06. Verfasst von Catherine Nichols Widmann und 2 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Cognitive sequelae after recovery from an initial COVID-19 disease are present in a subset of affected individuals, coalescing around several important issues such as effects of age, COVID-19 disease severity, comorbidities, and other factors. Some neuropsychological symptoms appear more common among certain patient populations. Comorbidities may complicate neuropsychological assessment as well. Hence, we need a guideline-based evaluation to guide neuropsychological rehabilitation. Drawing from the recent revision of the German National Guideline for the Long- and Post-COVID Syndrome and current advances in international guidance on neuropsychological assessment, this article provides practical and scientifically informed recommendations for the neuropsychological assessment of individuals recovering from coronavirus-related diseases.
Zitieren
APA
Widmann, C. N., Kolano, J., & Peper, M. (2023). Improving Neuropsychological Rehabilitation for COVID-19 Patients. Zeitschrift für Neuropsychologie, 34(2), 57-70. https://doi.org/10.1024/1016-264x/a000373
Vancouver
Widmann CN, Kolano J, Peper M. Improving Neuropsychological Rehabilitation for COVID-19 Patients. Zeitschrift für Neuropsychologie. 2023;34(2):57-70. doi:10.1024/1016-264x/a000373
BibTeX
@article{Widmann2023,
author = {Widmann, Catherine Nichols and Kolano, Juliana and Peper, Martin},
title = {Improving Neuropsychological Rehabilitation for COVID-19 Patients},
journal = {Zeitschrift für Neuropsychologie},
year = {2023},
volume = {34},
number = {2},
pages = {57--70},
doi = {10.1024/1016-264x/a000373}
}
EUVIMED